JOINN Labs and Biomere establish a global nonclinical CRO
The JOINN Labs / Biomere merger strategically leverages and combines the reputations of JOINN as a pioneer in commercial GLP services in China with Biomere’s specialty, discovery-based focus. In vivo models range from rodents to NHPs, specializing in ocular, autoimmune, inflammation, metabolic, neurological and viral studies. With locations in the USA and China, we are ideally suited to help our clients advance their novel therapies from early discovery through development.